Clincosm LogoSign in Get a demo

Hepatic Impairment

Showing 26 - 50 of 211
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatic Impairment Trial in San Antonio (Tavapadon)

Active, not recruiting
  • Hepatic Impairment
  • Miami, Florida
  • +2 more
Jan 18, 2023

Prevention of Thromboembolic Events, Atrial Fibrillation, Acute Myocardial Infarction Trial in Kiel (Asundexian (BAY2433334))

Recruiting
  • Prevention of Thromboembolic Events
  • +4 more
  • Asundexian (BAY2433334)
  • Kiel, Schleswig-Holstein, Germany
    CRS-Kiel
Jan 17, 2023

Hepatic Impairment Trial in China (Orelabrutinib Tablets)

Not yet recruiting
  • Hepatic Impairment
  • Orelabrutinib Tablets
  • Bengbu, Anhui, China
  • +4 more
Jan 12, 2023

Hepatic Impairment Trial (S-217622)

Recruiting
  • Hepatic Impairment
  • Miami, Florida
  • +3 more
Jan 9, 2023

Hepatic Impairment Trial (Vorasidenib)

Not yet recruiting
  • Hepatic Impairment
  • (no location specified)
Dec 30, 2022

Hepatic Impairment Trial in Tampa (Fosmanogepix)

Recruiting
  • Hepatic Impairment
  • Tampa, Florida
    Genesis Clinical Research, LLC
Dec 13, 2022

Hepatic Impairment Trial in Miami, Orlando, San Antonio (Cedirogant)

Terminated
  • Hepatic Impairment
  • Miami, Florida
  • +2 more
Dec 7, 2022

Hepatic Impairment Trial in Miami, Orlando, Knoxville (Enasidenib)

Recruiting
  • Hepatic Impairment
  • Miami, Florida
  • +4 more
Nov 27, 2022

Hepatic Impairment Trial in Chula Vista, Miami (MK-8189)

Completed
  • Hepatic Impairment
  • Chula Vista, California
  • +1 more
Nov 23, 2022

Hepatic Impairment, Healthy Subjects Trial in Kiel, Jozefow (Aprocitentan)

Completed
  • Hepatic Impairment
  • Healthy Subjects
  • Kiel, Germany
  • +1 more
Nov 22, 2022

Healthy, Hepatic Impairment Trial in Porto (Cenerimod)

Recruiting
  • Healthy
  • Hepatic Impairment
  • Porto, Portugal
    BlueClinical Phase 1 Hospital de Prelado
Nov 15, 2022

Hepatic Impairment Trial in München, Bratislava (Cagrilintide)

Not yet recruiting
  • Hepatic Impairment
  • München, Germany
  • +1 more
Nov 10, 2022

Hepatic Impairment, Healthy Trial in Kiel, Munchen (Lazertinib)

Completed
  • Hepatic Impairment
  • Healthy
  • Kiel, Germany
  • +1 more
Nov 9, 2022

Hepatic Impairment Trial (20 mg HC-ER)

Completed
  • Hepatic Impairment
  • 20 mg HC-ER
  • (no location specified)
Nov 8, 2022

Hepatic Impairment Trial in Chendu (Yimitasvir Phosphate)

Completed
  • Hepatic Impairment
  • Yimitasvir Phosphate
  • Chendu, Sichuan, China
    West China Hospital of Sichuan University
Oct 25, 2022

Hepatic Impairment Trial (oral dose of 200 mg pacritinib twice daily (BID))

Not yet recruiting
  • Hepatic Impairment
  • oral dose of 200 mg pacritinib twice daily (BID)
  • (no location specified)
Sep 23, 2022

Hepatic Impairment Trial in San Antonio (Iptacopan)

Completed
  • Hepatic Impairment
  • San Antonio, Texas
    Novartis Investigative Site
Sep 20, 2022

Hepatic Impairment Trial in Tustin, Orlando (Surufatinib)

Completed
  • Hepatic Impairment
  • Tustin, California
  • +1 more
Aug 29, 2022

Hepatic Impairment Trial in Miami, Orlando (Tepotinib)

Completed
  • Hepatic Impairment
  • Miami, Florida
  • +1 more
Aug 22, 2022

Hepatic Impairment Trial (Chiglitazar)

Not yet recruiting
  • Hepatic Impairment
  • (no location specified)
Aug 23, 2022

Pharmacokinetics, Hepatic Impairment Trial in Knoxville (MDMA)

Not yet recruiting
  • Pharmacokinetics
  • Hepatic Impairment
  • Knoxville, Tennessee
    Alliance for Multispecialty Research, LLC.
Aug 17, 2022

Hepatic Impairment Trial in Beijing (SHR4640)

Active, not recruiting
  • Hepatic Impairment
  • Beijing, Beijing, China
    Meixia Wang
Aug 9, 2022

Hepatic Impairment Trial in Morehead City, San Antonio (Pelacarsen)

Recruiting
  • Hepatic Impairment
  • Morehead City, North Carolina
  • +1 more
Aug 8, 2022

Hepatic Impairment Trial (TNO155)

Not yet recruiting
  • Hepatic Impairment
  • (no location specified)
Aug 4, 2022

Hepatic Impairment Trial (VIR-2218)

Not yet recruiting
  • Hepatic Impairment
  • (no location specified)
Jul 29, 2022